Reviva Pharmaceuticals News

Maxim Group Maintains Reviva Pharmaceuticals(RVPH.US) With Hold Rating

Moomoo NewsSep 6 13:31 ET

Maxim Group Reaffirms Their Hold Rating on Reviva Pharmaceuticals Holdings (RVPH)

TipRanksSep 6 12:37 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaAug 26 09:56 ET

Maxim Group Downgrades Reviva Pharmaceuticals(RVPH.US) to Hold Rating

Moomoo NewsAug 16 08:31 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaAug 16 08:04 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaJul 11 06:34 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaJun 20 06:15 ET

HC Wainwright & Co. Reiterates Buy on Reviva Pharmaceuticals, Maintains $14 Price Target

BenzingaJun 20 06:15 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaJun 11 06:17 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaMay 28 08:22 ET

Maxim Group Remains a Buy on Reviva Pharmaceuticals Holdings (RVPH)

TipRanksMay 16 15:40 ET

Analysts Are Bullish on Top Healthcare Stocks: Reviva Pharmaceuticals Holdings (RVPH), Roivant Sciences (ROIV)

TipRanksApr 22 06:26 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaApr 22 06:16 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaApr 16 10:01 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaMar 25 06:30 ET

Optimistic Buy Rating for Reviva Pharmaceuticals Based on Brilaroxazine's Broad Therapeutic Promise

TipRanksMar 25 06:30 ET

Reviva Pharmaceuticals Analyst Ratings

BenzingaFeb 20 07:18 ET

Buy Rating Affirmed for Reviva Pharmaceuticals on Brilaroxazine's Promise in Neuropsychiatry

TipRanksFeb 20 06:27 ET

Reviva Pharmaceuticals: A Prime Acquisition Target in the Neurology Biopharma Sector With a Strong Buy Rating

TipRanksDec 26, 2023 06:17 ET

HC Wainwright & Co. Reiterates Buy on Reviva Pharmaceuticals, Maintains $20 Price Target

BenzingaDec 26, 2023 06:16 ET